Modern strategy and standards of treatment of lower eyelid skin malignant neoplasms

Abstract

Cases of surgical treatment of basal cell skin carcinoma of the lower eyelid are rarely described in the world literature. Perhaps this is due to the search for new non-surgical treatment methods or to the fact that this localization is poorly represented in the total incidence of basal cell skin cancer. However, the operative method, recommended as the main line of treatment by both domestic and foreign clinical recommendations, is still recognized as the most radical and aesthetically acceptable method of treatment. Non-radical treatment of the tumor leads, in turn, to relapses of the disease, to the emergence of systemic metastatic foci due to the lymphogenic and hematogenic spread of tumor cells. In the article we describe the experience of surgical treatment of patients suffering from basal cell skin carcinoma of the lower eyelid of varying degrees of extension.

Keywords

basal cell skin carcinoma / lower eyelid / surgical treatment

References

[1] Weissferdt A, Kalhor N, Moran CA. Cutaneous basal cell carcinoma with distant metastasis to thorax and bone: A clinicopathological and immunohistochemical study of 15 cases. Virchows Arch. 2017;470(6):687–694. DOI: 10.1007/s00428-017-2121-3

[2] Weissferdt A., Kalhor N., Moran C.A. Cutaneous basal cell carcinoma with distant metastasis to thorax and bone: A clinicopathological and immunohistochemical study of 15 cases // Virchows Arch. 2017. Vol. 470, No. 6. P. 687–694. DOI: 10.1007/s00428-017-2121-3

[3] Monroe M, Kakarala K. Management of advanced basal cell carcinoma of the head and neck. Otolaryngol Clin North Am. 2021;54(2):271–280. DOI: 10.1016/j.otc.2020.11.003

[4] Monroe M., Kakarala K. Management of advanced basal cell carcinoma of the head and neck // Otolaryngol Clin North Am. 2021. Vol. 54, No. 2. P. 271–280. DOI: 10.1016/j.otc.2020.11.003

[5] Phan K, Oh LJ, Goyal S, et al. Recurrence rates following surgical excision of periocular basal cell carcinomas: systematic review and meta-analysis. J Dermatolog Treat. 2020;31(6):597–601. DOI: 10.1080/09546634.2019.1698702

[6] Phan K., Oh L.J., Goyal S., et al. Recurrence rates following surgical excision of periocular basal cell carcinomas: systematic review and meta-analysis // J Dermatolog Treat. 2020. Vol. 31, No. 6. P. 597–601. DOI: 10.1080/09546634.2019.1698702

[7] Obshcherossiiskii natsional’nyi soyuz “Assotsiatsiya onkologov Rossii”, Assotsiatsiya spetsialistov po problemam melanomy, Obshcherossiiskaya obshchestvennaya organizatsiya “Rossiiskoe obshchestvo klinicheskoi onkologii”, Obshcherossiiskaya obshchestvennaya organizatsiya “Assotsiatsiya vrachei-oftalmologov”. Klinicheskie rekomendatsii “Bazalnokletochnyi rak kozhi”. 2020. 85 p. (In Russ.)

[8] Общероссийский национальный союз «Ассоциация онкологов России», Ассоциация специалистов по проблемам меланомы, Общероссийская общественная организация «Российское общество клинической онкологии», Общероссийская общественная организация «Ассоциация врачей-офтальмологов». Клинические рекомендации «Базальноклеточный рак кожи». 2020. 85 с

[9] Vaccari S, Barisani A, Schiavi C, et al. Basal cell carcinoma of the eyelid margin: Dermoscopic clues in a case series. Dermatol Ther. 2021;34(4): e15006. DOI: 10.1111/dth.15006

[10] Vaccari S., Barisani A., Schiavi C., et al. Basal cell carcinoma of the eyelid margin: Dermoscopic clues in a case series // Dermatol Ther. 2021. Vol. 34, No. 4. ID e15006. DOI: 10.1111/dth.15006

[11] Brovkina AF, Lerner MYu. Eyelid skin cancer: еpidemiology, prognosis. Head and Neck Tumors (HNT). 2017;7(1):81–85. (In Russ.) DOI: 10.17650/2222-1468-2017-7-1-81-85

[12] Бровкина А.Ф., Лернер М.Ю. Рак кожи век: эпидемиология, прогноз // Опухоли головы и шеи. 2017. Т. 7, № 1. С. 81–85. DOI: 10.17650/2222-1468-2017-7-1-81-85

[13] Silverman N, Shinder R. What’s new in eyelid tumors. Asia Pac J Ophthalmol (Phila). 2017;6(2):143–152. DOI: 10.22608/APO.201701

[14] Silverman N., Shinder R. What’s new in eyelid tumors // Asia Pac J Ophthalmol (Phila). 2017. Vol. 6, No. 2. P. 143–152. DOI: 10.22608/APO.201701

[15] Lai V, Cranwell W, Sinclair R. Epidemiology of skin cancer in the mature patient. Clin Dermatol. 2018;36(2):167–176. DOI: 10.1016/j.clindermatol.2017.10.008

[16] Lai V., Cranwell W., Sinclair R. Epidemiology of skin cancer in the mature patient // Clin Dermatol. 2018. Vol. 36, No. 2. P. 167–176. DOI: 10.1016/j.clindermatol.2017.10.008

[17] Leffell DJ, Carucci JA. Management of Skin Cancer. DeVita VT, Hellman S, Rosenberg SA, editors. Cancer: Principles and Practice of Onco logy. 6th edition. Philadelphia PA: Lippincott Williams & Wilkins; 2001.

[18] Leffell D.J., Carucci J.A. Management of Skin Cancer. Cancer: principles and practice of oncology. 6th edition / edited by V.T. DeVita, S. Hellman, S.A. Rosenberg. Philadelphia PA: Lippincott Williams & Wilkins; 2001.

[19] Furdova A, Lukacko P. Periocular basal cell carcinoma predictors for recurrence and infiltration of the orbit. J Craniofac Surg. 2017;28(1): e84–e87. DOI: 10.1097/SCS.0000000000003242

[20] Furdova A., Lukacko P. Periocular basal cell carcinoma predictors for recurrence and infiltration of the orbit // J Craniofac Surg. 2017. Vol. 28, No. 1. P. e84–e87. DOI: 10.1097/SCS.0000000000003242

[21] Prídavková Z, Bieliková A, Ferková N, Lysková D. Recurrent periocular basal cell carcinoma. Case report. Cesk Slov Oftalmol. 2021;77(4):208–213. DOI: 10.31348/2021/24

[22] Prídavková Z., Bieliková A., Ferková N., Lysková D. Recurrent periocular basal cell carcinoma. Case report // Cesk Slov Oftalmol. 2021. Vol. 77, No. 4. P. 208–213. DOI: 10.31348/2021/24

[23] Weesie F, Naus NC, Vasilic D, et al. Recurrence of periocular basal cell carcinoma and squamous cell carcinoma after Mohs micrographic surgery: a retrospective cohort study. Br J Dermatol. 2019;180(5):1176–1182. DOI: 10.1111/bjd.17516

[24] Weesie F., Naus N.C., Vasilic D., et al. Recurrence of periocular basal cell carcinoma and squamous cell carcinoma after Mohs micrographic surgery: a retrospective cohort study // Br J Dermatol. 2019. Vol. 180, No. 5. P. 1176–1182. DOI: 10.1111/bjd.17516

[25] Leibovitch I, McNab A, Sullivan T, et al. Orbital invasion by periocular basal cell carcinoma. Ophthalmology. 2005;112(4):717–723. DOI: 10.1016/j.ophtha.2004.11.036

[26] Leibovitch I., McNab A., Sullivan T., et al. Orbital invasion by periocular basal cell carcinoma // Ophthalmology. 2005. Vol. 112, No. 4. P. 717–723. DOI: 10.1016/j.ophtha.2004.11.036

[27] Kim DP, Kus KJB, Ruiz E. Basal cell carcinoma review. Hematol Oncol Clin North Am. 2019;33(1):13–24. DOI: 10.1016/j.hoc.2018.09.004

[28] Kim D.P., Kus K.J.B., Ruiz E. Basal Cell Carcinoma Review // Hematol Oncol Clin North Am. 2019. Vol. 33, No. 1. P. 13–24. DOI: 10.1016/j.hoc.2018.09.004

[29] Iuliano A, Strianese D, Uccello G, et al. Risk factors for orbital exenteration in periocular Basal cell carcinoma. Am J Ophthalmol. 2012;153(2):238–241.e1. DOI: 10.1016/j.ajo.2011.08.004

[30] Iuliano A., Strianese D., Uccello G., et al. Risk factors for orbital exenteration in periocular Basal cell carcinoma // Am J Ophthalmol. 2012. Vol. 153, No. 2. P. 238–241.e1. DOI: 10.1016/j.ajo.2011.08.004

[31] Sun MT, Wu A, Figueira E, et al. Management of periorbital basal cell carcinoma with orbital invasion. Future Oncol. 2015;11(22): 3003–3010. DOI: 10.2217/fon.15.190

[32] Sun M.T., Wu A., Figueira E., et al. Management of periorbital basal cell carcinoma with orbital invasion // Future Oncol. 2015. Vol. 11, No. 22. P. 3003–3010. DOI: 10.2217/fon.15.190

[33] Mehta KS, Mahajan VK, Chauhan PS, et al. Metastatic Basal cell carcinoma: a biological continuum of Basal cell carcinoma? Case Rep Dermatol Med. 2012;2012:157187. DOI: 10.1155/2012/157187

[34] Mehta K.S., Mahajan V.K., Chauhan P.S., et al. Metastatic Basal cell carcinoma: a biological continuum of Basal cell carcinoma? // Case Rep Dermatol Med. 2012. Vol. 2012. ID 157187. DOI: 10.1155/2012/157187

RIGHTS & PERMISSIONS

Polyakov A.P., Davydov D.V., Novikova I.V., Sugaipov A.L., Kuznetsova O.S., Naumova E.A.